vs
MEDIFAST INC（MED）与Purple Innovation, Inc.（PRPL）财务数据对比。点击上方公司名可切换其他公司
Purple Innovation, Inc.的季度营收约是MEDIFAST INC的1.9倍（$140.7M vs $75.1M），Purple Innovation, Inc.同比增速更快（9.1% vs -36.9%），MEDIFAST INC自由现金流更多（$-6.6M vs $-7.8M），过去两年Purple Innovation, Inc.的营收复合增速更高（8.3% vs -34.4%）
迈德福斯特是一家总部位于美国马里兰州巴尔的摩的营养减重企业，该公司研发、分销并销售减重及健康相关产品，销售渠道涵盖官方网站、多层次营销、电话销售以及品牌加盟减重诊所。
Purple Carrot是一家总部位于马萨诸塞州尼达姆市的全植物性餐包品牌，由安迪·莱维特创立，每周为订阅用户提供预制餐品和自制餐包。据《大都会》2022年报道，对比美式标准餐食，该品牌每份餐包的碳排放量可降低72%，主打低碳环保的纯植物饮食方案。
MED vs PRPL — 直观对比
营收规模更大
PRPL
是对方的1.9倍
$75.1M
营收增速更快
PRPL
高出46.0%
-36.9%
自由现金流更多
MED
多$1.2M
$-7.8M
两年增速更快
PRPL
近两年复合增速
-34.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.1M | $140.7M |
| 净利润 | — | $-3.2M |
| 毛利率 | 69.4% | 41.9% |
| 营业利润率 | -10.4% | -1.6% |
| 净利率 | — | -2.3% |
| 营收同比 | -36.9% | 9.1% |
| 净利润同比 | — | 62.1% |
| 每股收益（稀释后） | $-1.64 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MEDPRPL
| Q4 25 | $75.1M | $140.7M | ||
| Q3 25 | $89.4M | $118.8M | ||
| Q2 25 | $105.6M | $105.1M | ||
| Q1 25 | $115.7M | $104.2M | ||
| Q4 24 | $119.0M | $129.0M | ||
| Q3 24 | $140.2M | $118.6M | ||
| Q2 24 | $168.6M | $120.3M | ||
| Q1 24 | $174.7M | $120.0M |
净利润MEDPRPL
| Q4 25 | — | $-3.2M | ||
| Q3 25 | $-2.3M | $-11.7M | ||
| Q2 25 | $2.5M | $-17.3M | ||
| Q1 25 | $-772.0K | $-19.1M | ||
| Q4 24 | — | $-8.5M | ||
| Q3 24 | $1.1M | $-39.2M | ||
| Q2 24 | $-8.2M | $27.0K | ||
| Q1 24 | $8.3M | $-50.2M |
毛利率MEDPRPL
| Q4 25 | 69.4% | 41.9% | ||
| Q3 25 | 69.5% | 42.8% | ||
| Q2 25 | 72.6% | 35.9% | ||
| Q1 25 | 72.8% | 39.4% | ||
| Q4 24 | 74.1% | 42.9% | ||
| Q3 24 | 75.4% | 29.7% | ||
| Q2 24 | 73.2% | 40.7% | ||
| Q1 24 | 72.8% | 34.8% |
营业利润率MEDPRPL
| Q4 25 | -10.4% | -1.6% | ||
| Q3 25 | -4.6% | -10.2% | ||
| Q2 25 | -1.0% | -13.5% | ||
| Q1 25 | -1.1% | -13.9% | ||
| Q4 24 | 0.6% | -6.0% | ||
| Q3 24 | 1.5% | -39.5% | ||
| Q2 24 | -4.7% | -12.1% | ||
| Q1 24 | 4.5% | -19.3% |
净利率MEDPRPL
| Q4 25 | — | -2.3% | ||
| Q3 25 | -2.5% | -9.9% | ||
| Q2 25 | 2.3% | -16.5% | ||
| Q1 25 | -0.7% | -18.4% | ||
| Q4 24 | — | -6.6% | ||
| Q3 24 | 0.8% | -33.1% | ||
| Q2 24 | -4.8% | 0.0% | ||
| Q1 24 | 4.8% | -41.8% |
每股收益（稀释后）MEDPRPL
| Q4 25 | $-1.64 | $0.03 | ||
| Q3 25 | $-0.21 | $0.11 | ||
| Q2 25 | $0.22 | $0.16 | ||
| Q1 25 | $-0.07 | $0.18 | ||
| Q4 24 | $0.08 | $0.08 | ||
| Q3 24 | $0.10 | $0.36 | ||
| Q2 24 | $-0.75 | $0.00 | ||
| Q1 24 | $0.76 | $0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.3M | $24.3M |
| 总债务越低越好 | — | $126.7M |
| 股东权益账面价值 | $198.9M | $-29.7M |
| 总资产 | $248.0M | $296.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MEDPRPL
| Q4 25 | $167.3M | $24.3M | ||
| Q3 25 | $173.5M | $32.4M | ||
| Q2 25 | $162.7M | $34.2M | ||
| Q1 25 | $164.6M | $21.6M | ||
| Q4 24 | $162.3M | $29.0M | ||
| Q3 24 | $170.0M | $23.4M | ||
| Q2 24 | $163.5M | $23.4M | ||
| Q1 24 | $156.4M | $34.5M |
总债务MEDPRPL
| Q4 25 | — | $126.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | — | $50.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MEDPRPL
| Q4 25 | $198.9M | $-29.7M | ||
| Q3 25 | $214.7M | $-26.9M | ||
| Q2 25 | $216.0M | $-15.6M | ||
| Q1 25 | $211.0M | $1.3M | ||
| Q4 24 | $210.1M | $20.2M | ||
| Q3 24 | $207.3M | $28.0M | ||
| Q2 24 | $205.3M | $66.4M | ||
| Q1 24 | $211.0M | $65.5M |
总资产MEDPRPL
| Q4 25 | $248.0M | $296.3M | ||
| Q3 25 | $268.2M | $302.1M | ||
| Q2 25 | $269.3M | $303.8M | ||
| Q1 25 | $280.0M | $293.8M | ||
| Q4 24 | $284.2M | $307.8M | ||
| Q3 24 | $291.2M | $309.3M | ||
| Q2 24 | $293.5M | $362.1M | ||
| Q1 24 | $302.8M | $382.1M |
负债/权益比MEDPRPL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.3M | $-5.8M |
| 自由现金流经营现金流 - 资本支出 | $-6.6M | $-7.8M |
| 自由现金流率自由现金流/营收 | -8.8% | -5.5% |
| 资本支出强度资本支出/营收 | 1.8% | 1.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $1.2M | $-41.9M |
8季度趋势，按日历期对齐
经营现金流MEDPRPL
| Q4 25 | $-5.3M | $-5.8M | ||
| Q3 25 | $12.1M | $-968.0K | ||
| Q2 25 | $-3.4M | $-4.0M | ||
| Q1 25 | $3.4M | $-23.1M | ||
| Q4 24 | $-4.9M | $6.8M | ||
| Q3 24 | $9.1M | $1.1M | ||
| Q2 24 | $13.1M | $-8.9M | ||
| Q1 24 | $7.3M | $-16.8M |
自由现金流MEDPRPL
| Q4 25 | $-6.6M | $-7.8M | ||
| Q3 25 | $10.8M | $-1.8M | ||
| Q2 25 | $-4.8M | $-7.0M | ||
| Q1 25 | $1.9M | $-25.3M | ||
| Q4 24 | $-7.2M | $5.7M | ||
| Q3 24 | $7.7M | $101.0K | ||
| Q2 24 | $11.1M | $-11.0M | ||
| Q1 24 | $5.4M | $-19.9M |
自由现金流率MEDPRPL
| Q4 25 | -8.8% | -5.5% | ||
| Q3 25 | 12.0% | -1.5% | ||
| Q2 25 | -4.5% | -6.6% | ||
| Q1 25 | 1.6% | -24.3% | ||
| Q4 24 | -6.1% | 4.4% | ||
| Q3 24 | 5.5% | 0.1% | ||
| Q2 24 | 6.6% | -9.2% | ||
| Q1 24 | 3.1% | -16.5% |
资本支出强度MEDPRPL
| Q4 25 | 1.8% | 1.4% | ||
| Q3 25 | 1.5% | 0.7% | ||
| Q2 25 | 1.3% | 2.8% | ||
| Q1 25 | 1.3% | 2.2% | ||
| Q4 24 | 1.9% | 0.8% | ||
| Q3 24 | 1.0% | 0.9% | ||
| Q2 24 | 1.1% | 1.7% | ||
| Q1 24 | 1.1% | 2.5% |
现金转化率MEDPRPL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.36× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.04× | — | ||
| Q2 24 | — | -330.22× | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MED
暂无分部数据
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
